After Years of Unidentified Pain, Teenager Finds Relief at Hadassah

Wednesday, Nov 13 2019

A very active, athletic 17-year-old girl arrived at Hadassah Hospital Ein Kerem complaining of pain in her stomach. She had no idea there was a massive growth in her abdomen that weighed more than six pounds.

“Tamar [not her real name] complained of abdominal pain from an early age,” her mother reports. “We contacted several doctors who did a variety of tests, but the results suggested everything was normal, and we thought all was okay. We attributed the pain to the stresses caused by life changes, such as moving our home, school examinations, and an unbalanced diet.”

One day toward evening, Tamar's mother recalls, “Tamar began complaining of strong abdominal pain. Something about the pain was different this time. She was really suffering, and her abdomen had suddenly swelled up. Tamar is a very thin girl and physically quite small. We were alarmed by the swelling. It was clear that a comprehensive examination was needed.”

Tamar’s mother took her to Hadassah Ein Kerem, where doctors found the huge growth that now filled Tamar’s abdominal and pelvic cavities.

Senior surgeon Dr. Uri Dior, an expert in gynecologic laparoscopic surgery, explains, “In the initial examination, we found a lump and needed to ascertain its source. During testing we discovered that the growth stretched from the pelvic area to the liver, which is most unusual. From our tests, we were confident the tumor was benign, but we couldn’t be certain. It was obvious we would have to operate on Tamar immediately.”

Hadassah’s medical specialists decided that, despite the abnormal size of the tumor, they would try to remove it using a minimally invasive laparoscopic approach to avoid a large abdominal incision. As the surgeons, Dr. Dior and Dr. Avi Ben-Shushan, director of Hadassah’s Gynecologic Oncology Service, explain, “Laparoscopic surgery means a far shorter hospitalization, much faster recovery, significantly less post-operative pain, and lower risk of infection and other complications. And, of course, the cosmetic result is significantly different. Rather than a large scar, there are tiny scars that often become invisible.”

The surgeons add, “Time and again we see the value of the minimally invasive procedure. In Tamar’s case, where a dynamic young girl’s life plans were turned upside down in an instant, we didn’t want the surgery to add to the trauma she had already experienced.”

The tumor, as expected, was benign. It is a common type of tumor among fertile women, the doctors note, but its enormity at such a young age was most unusual. "Nearly three liters of fluid and tissue were sucked out of the tumor,” Dr. Ben-Shushan says. “Since the source of the tumor was ovarian,” he explains, “it was very important for us to preserve Tamar’s ovarian tissue. At the end of the surgery, we reconstructed her ovary.  We expect her to have a fully functioning ovary.” 

Three days later, Tamar was discharged from the hospital.

“We thank the Lord for sending his best emissaries, Dr. Dior and Dr. Ben-Shushan,” says Tamar’s mother.

Learn more about the Hadassah Medical Organization.

Related Stories


Wednesday, Dec 2 2020

Hadassah Opens Follow-Up Clinic for Recovered COVID-19 Patients

In response to the large number of COVID-19 patients suffering from lingering health issues long after they recover from the virus, Hadassah Hospital Ein Kerem has opened a multidisciplinary clinic at its Pulmonary Institute to monitor and assess their physical and psychological symptoms.


Tuesday, Dec 1 2020

One in 200,000: Identical Triplets Born at Hadassah Hospital Mount Scopus

Last year, Tamar gave birth to a stillborn baby. When she became pregnant again, she initially didn’t rush to have an ultrasound because of the pandemic. But she wanted to make sure there was a heartbeat, and so she went to Hadassah Hospital Mount Scopus for that ultrasound. There were three heartbeats—belonging to three identical babies!


Tuesday, Dec 1 2020

Hadassah Completes Phase I Trial With Israeli-Made COVID-19 Vaccine

Phase I of the first clinical trial with Brilife, the COVID-19 vaccine developed by the Israel Institute for Biological Research, was completed at Hadassah Hospital Ein Kerem on November 26, when the 40th participant received the final dose.


Tuesday, Nov 24 2020

[Hadassah On Call Podcast] COVID's Long-Term Health Impact, an Insider's Perspective

It's no longer enough to find a COVID-19 cure. Each day, we're discovering long-term complications for those who have recovered from the virus.


Donation Questions


(800) 928-0685

Membership Questions


(800) 664-5646

Israel Travel


(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

More ›

Show More